Food insecurity from Russia’s war in Ukraine has triggered instability in vulnerable countries, spy agency says
The unclassified 8-page report was mandated by Congress.
Medicare drug price negotiations may have a muted impact on drugmakers in the near term
Many of the drugs are already facing strong competition from other branded medications or patent expirations that will open the market to generic alternatives.
Google announces event for Oct. 4, where new Pixel phone and smartwatch expected
Google is set to debut the Pixel 8 and Pixel 8 Pro, which will follow last year’s Pixel 7 and Pixel 7 Pro.
Warren Buffett, who turns 93, is at the top of his game as he pushes Berkshire Hathaway to new heights
Berkshire shares have roared back to an all-time high on record operating profit, making it the biggest nontech company by market capitalization.
Comeback kids: These stocks could be ready to regain their 2023 momentum after a rough August
These stocks sold off in a big way in August. However, they’re beloved by Wall Street and rallied to start the year.
Hurricane Idalia barrels into Georgia after hitting Florida coast, leaving at least two dead
Hurricane Idalia slammed Florida’s Big Bend with maximum sustained winds of more than 100 miles per hour and catastrophic flooding.
Sunrun could rally almost 40% from Tuesday’s close, Citigroup says
The bank upgraded shares of the solar energy and battery storage company to buy, citing an attractive valuation.
Opioid overdose antidote Narcan will be widely available over the counter next week
A two-pack of the opioid overdose antidote will retail for $44.99, which some experts fear is too high.
Guggenheim maintains Tesla sell rating despite the stock’s strong performance this week
Despite the stock’s gains this week, Guggenheim remains bearish on Tesla.